Pasithea Therapeutics KTTAW
NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT

Pasithea Therapeutics Corp. (KTTAW) Other financing activities (2025)

Pasithea Therapeutics' (KTTAW) quarterly Other financing activities came in at $53.4 million in Q4 2025, up 2523.79% quarter-over-quarter from -$2.2 million in Q3 2025.

Analysis

Pasithea Therapeutics Corp. (KTTAW) Other financing activities (2025) Analysis & Trends

Pasithea Therapeutics has disclosed Other financing activities across 1 years of filings, most recently posting $53.4 million for Q4 2025.

  • In Q4 2025, Other financing activities changed N/A year-over-year to $53.4 million; the TTM figure through Dec 2025 stood at $55.4 million (changed N/A YoY), while the FY2025 annual figure was $55.4 million, up 1008.76% from the prior year.
  • Other financing activities came in at $53.4 million for Q4 2025 at Pasithea Therapeutics, up from -$2.2 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $53.4 million in Q4 2025 to a low of -$2.2 million in Q3 2025.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 53.41 Mn
Sep 30, 2025 -2.20 Mn
Jun 30, 2025 4.04 Mn
Mar 31, 2025 179,310.00